Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes. 2011

Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

We have selected for resistance to etravirine (ETR) and efavirenz (EFV) in tissue culture using three subtype B, three subtype C, and two CRF02_AG clinical isolates, grown in cord blood mononuclear cells. Genotypic analysis was performed at baseline and at various weeks of selection. Phenotypic resistance in regard to ETR, EFV, and nevirapine (NVP) was evaluated at weeks 25 to 30 for all ETR-selected viruses and in viral clones that contained specific resistance mutations that were inserted by site-directed mutagenesis into pNL-4.3 and AG plasmids. The results show that ETR selected mutations at positions V90I, K101Q, E138K, V179D/E/F, Y181C, V189I, G190E, H221H/Y, and M230L and that E138K was the first of these to emerge in most instances. The time to the emergence of resistance was longer in the case of ETR (18 weeks) compared to EFV (11 weeks), and no differences in the patterns of emergent mutations could be documented between the B and non-B subtypes. Viral clones containing E138K displayed low-level phenotypic resistance to ETR (3.8-fold) and modestly impaired replication capacity (2-fold) compared to wild-type virus. ETR-selected virus showed a high degree of cross-resistance to NVP but not to EFV. We identified K101Q, E138K, V179E, V189I, G190E, and H221Y as mutations not included among the 17 currently recognized resistance-associated mutations for ETR.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
October 2016, The Journal of antimicrobial chemotherapy,
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
February 2014, Journal of virology,
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
January 2012, Journal of acquired immune deficiency syndromes (1999),
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
April 2011, Antimicrobial agents and chemotherapy,
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
January 2024, The Journal of infectious diseases,
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
September 2013, The Journal of antimicrobial chemotherapy,
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
January 2010, AIDS (London, England),
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
September 2009, Journal of medical virology,
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
January 2011, Enfermedades infecciosas y microbiologia clinica,
Eugene L Asahchop, and Maureen Oliveira, and Mark A Wainberg, and Bluma G Brenner, and Daniela Moisi, and Thomas d'Aquin Toni, and Cecile L Tremblay
June 2011, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!